Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21601644 | 0.90 | APLNR (0.51) | APLNRMEN1KMT2ACNR1CNR2 | |
| SCHEMBL23001571 | 0.82 | APLNR (0.56) | APLNRMEN1KMT2ACNR1CNR2 | |
| SCHEMBL31155834 | 0.79 | MEN1 (0.48) | MAPTMEN1KMT2ACNR1CNR2 | |
| SCHEMBL12522890 | 0.78 | APLNR (0.83) | APLNRMEN1KMT2AALDH1A1HDAC3 | |
| SCHEMBL24851928 | 0.78 | APLNR (0.67) | APLNRMEN1KMT2AALDH1A1HDAC3 | |
| SCHEMBL23789919 | 0.76 | APLNR (0.44) | APLNRMEN1KMT2ACNR1CNR2 | |
| SCHEMBL14566055 | 0.76 | MAPT (0.52) | MAPTCNR1CNR2HDAC3HDAC1 | |
| SCHEMBL3991925 | 0.75 | MAPT (0.55) | MAPTMEN1KMT2ACNR1CNR2 | |
| SCHEMBL1269158 | 0.74 | APLNR (0.71) | APLNRMEN1KMT2ACNR1CNR2 | |
| SCHEMBL14957586 | 0.74 | APLNR (0.57) | APLNRMAPTMEN1KMT2ACNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210277051-A1 | COMPOUND OR SALT THEREOF AND PREPARATION METHOD AND APPLICATION OF SAME | ZHEJIANG PEPTITES BIOTECH CO., LTD (CN) | 2021-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210277051-A1 | COMPOUND OR SALT THEREOF AND PREPARATION METHOD AND APPLICATION OF SAME | SEM1, REN, SETDB1 | APLNR 3444/4885MAPT 2495/4885MEN1 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.